Diagnosis and treatment of chorea syndromes (Q38332316)

2 September 2017

1 reference

title

Diagnosis and treatment of chorea syndromes (English)

1 reference

2 September 2017

0 references

Andreas Hermann

1

1 reference

2 September 2017

Ruth H Walker

series ordinal

2

1 reference

2 September 2017

language of work or name

1 reference

1 January 2015

1 reference

Current Neurology and Neuroscience Reports

2 September 2017

published in

1 reference

2 September 2017

volume

15

1 reference

2 September 2017

issue

2

1 reference

2 September 2017

page(s)

514

1 reference

Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea.

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Tubulin is a neuronal target of autoantibodies in Sydenham's chorea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Benign hereditary chorea: clinical, neuroimaging, and genetic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Mutations in TITF1 are not relevant to sporadic and familial chorea of unknown cause.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

A novel TITF-1 mutation causes benign hereditary chorea with response to levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Child neurology: differential diagnosis of a low CSF glucose in children and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Atypical GLUT1 deficiency with prominent movement disorder responsive to ketogenic diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

PRRT2 mutations and paroxysmal disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

PRRT2 mutation correlated with phenotype of paroxysmal kinesigenic dyskinesia and drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

PRRT2 links infantile convulsions and paroxysmal dyskinesia with migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Adult nonketotic hyperglycinemia (NKH) crisis presenting as severe chorea and encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Valproate-induced chorea and encephalopathy in atypical nonketotic hyperglycinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Movement disorders associated with chronic GM2 gangliosidosis. Case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Brain, blood, and iron: perspectives on the roles of erythrocytes and iron in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Aceruloplasminemia, an iron metabolic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Iron metabolism in the CNS: implications for neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Pathophysiology and treatment of neurodegeneration with brain iron accumulation in the pediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Remarkable improvement in adult Leigh syndrome with partial cytochrome c oxidase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

A missense mutation in the mitochondrial ND5 gene associated with a Leigh-MELAS overlap syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Adult-onset chorea and mitochondrial cytopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Leber hereditary optic neuropathy with chorea and dementia resembling Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Autopsy-proven Huntington's disease with 29 trinucleotide repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

The association of CAG repeat length with clinical progression in Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Huntington's disease phenocopy syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

The presymptomatic stage of neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Choreiform movements in spinocerebellar ataxia type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Extrapyramidal signs are a common feature of spinocerebellar ataxia type 17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Prevalence of dentatorubral-pallidoluysian atrophy in a large series of white patients with cerebellar ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Dentatorubral pallidoluysian atrophy in South Wales.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

The Haw River syndrome: dentatorubropallidoluysian atrophy (DRPLA) in an African-American family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Huntington's disease--like 2 can present as chorea-acanthocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Huntington's Disease-like 2 (HDL2) in North America and Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Phenotypic features of Huntington's disease-like 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Genotype-phenotype analysis in inherited prion disease with eight octapeptide repeat insertional mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

A novel ferritin light chain gene mutation in a Japanese family with neuroferritinopathy: description of clinical features and implications for genotype-phenotype correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

What is and what is not 'Fahr's disease'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Chorea-ballism associated with familial amyotrophic lateral sclerosis. A clinical, genetic, and neuropathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Association of chorea and motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Behavioral variant of frontotemporal dementia mimicking Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Clinical spectrum of ataxia-telangiectasia in adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Clinical features and molecular bases of neuroacanthocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Testing for acanthocytosis A prospective reader-blinded study in movement disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

A conserved sorting-associated protein is mutant in chorea-acanthocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Chorea-acanthocytosis genotype in the original critchley kentucky neuroacanthocytosis kindred

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Computational identification of phospho-tyrosine sub-networks related to acanthocyte generation in neuroacanthocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Erythrocyte membrane changes of chorea-acanthocytosis are the result of altered Lyn kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Gain-of-function Lyn induces anemia: appropriate Lyn activity is essential for normal erythropoiesis and Epo receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Chorein sensitivity of cytoskeletal organization and degranulation of platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

McLeod neuroacanthocytosis: genotype and phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Ablation of the Kell/Xk complex alters erythrocyte divalent cation homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Differential Diagnosis of Chorea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Hyperglycemic choreoathetosis: role of the putamen in pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Hypoglycemia-induced choreoathetosis associated with hyperintense basal ganglia lesions in T1-weighted brain MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Persistent chorea triggered by hyperglycemic crisis in diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Serum vitamin B12 deficiency and hyperhomocystinemia: a reversible cause of acute chorea, cerebellar ataxia in an adult with cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Chorea as a presenting feature of variant Creutzfeldt-Jakob disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Reversible choreoathetosis as the early onset of HIV-encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

HIV-induced chorea: evidence for basal ganglia dysregulation by SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Hemichorea with antiphospholipid antibodies in a patient with lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Primary Sjogren's syndrome presenting as a generalized chorea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Hemichorea in a patient with JAK2V617F blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Slow evolution of cerebellar degeneration and chorea in a man with anti-Yo antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Anti-NMDA-receptor encephalitis: a cause of psychiatric, seizure, and movement disorders in young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Treatment of Sydenham's chorea with intravenous immunoglobulin, plasma exchange, or prednisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Pharmacological treatment of chorea in Huntington's disease-good clinical practice versus evidence-based guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Long-term follow-up of Huntington disease treated by bilateral deep brain stimulation of the internal globus pallidus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Long-term follow-up of pallidal deep brain stimulation in two cases of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Bilateral deep brain stimulation for treatment of medically refractory paroxysmal nonkinesigenic dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Short and long term outcome of bilateral pallidal stimulation in chorea-acanthocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Effect of donepezil on motor and cognitive function in Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Factors associated with slow progression in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Weight loss in Huntington disease increases with higher CAG repeat number

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Dietary intake in adults at risk for Huntington disease: analysis of PHAROS research participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

PRRT2 mutations: A major cause of paroxysmal kinesigenic dyskinesia in the European population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Spectrum of movement disorders in neuroferritinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11910-014-0514-0

Therapeutic interventions for disease progression in Huntington's disease

21 January 2018

1 reference

12 December 2020

The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia

1 reference

12 December 2020

Schizophrenia in a patient with spinocerebellar ataxia 2: coincidence of two disorders or a neurodegenerative disease presenting with psychosis?

1 reference

12 December 2020

Chorea as the presenting feature of neurosyphilis

1 reference

12 December 2020

The clinical diagnosis of autosomal dominant spinocerebellar ataxias

1 reference

12 December 2020

Reversible chorea and focal dystonia in vitamin B12 deficiency

1 reference

12 December 2020

Chorein-sensitive polymerization of cortical actin and suicidal cell death in chorea-acanthocytosis

1 reference

12 December 2020

Chorea in the elderly with mutation positive polycythemia vera: a case report.

1 reference

12 December 2020

Isolated Chorea Associated with LGI1 Antibody

1 reference

12 December 2020

Movement disorders in childhood organic acidurias. Clinical, neuroimaging, and biochemical correlations

1 reference

12 December 2020

[Chorea-athetosis in the anti-Hu syndrome]

1 reference

12 December 2020

Case 1, 1995: psychosis, dementia, chorea, ataxia, and supranuclear gaze dysfunction

1 reference

12 December 2020

Chorea in new variant Creutzfeldt-Jacob disease

1 reference

12 December 2020

Chorea and rapidly progressive subcortical dementia in antiphospholipid syndrome.

1 reference

12 December 2020

GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak

1 reference

12 December 2020

New Perspectives on the Neuropathology in Huntington's Disease in the Human Brain and its Relation to Symptom Variation

1 reference

12 December 2020

10.1007/S11910-014-0514-0

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

1014664259

0 references

1 reference